B

Bergenbio ASA
OSE:BGBIO

Watchlist Manager
Bergenbio ASA
OSE:BGBIO
Watchlist
Price: 1.364 NOK 1.04% Market Closed
Market Cap: 53.3m NOK

Relative Value

There is not enough data to reliably calculate the relative value of BGBIO.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

BGBIO Relative Value
Base Case
Not Available
B
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
98
vs Industry
17
Median 3Y
57 934.7
Median 5Y
950 792.2
Industry
7.2
vs History
vs Industry
Median 3Y
-87.4
Median 5Y
-1 649.6
Industry
23.2
Forward
-0.4
vs History
vs Industry
Median 3Y
-79.9
Median 5Y
-1 705.8
Industry
19.3
vs History
vs Industry
Median 3Y
-79.9
Median 5Y
-1 703.6
Industry
22.5
vs History
98
vs Industry
71
Median 3Y
119.9
Median 5Y
2 696.1
Industry
2.7
vs History
vs Industry
4
Median 3Y
57 353.7
Median 5Y
950 415.6
Industry
7.5
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
9.4
vs History
0
vs Industry
23
Median 3Y
-86.2
Median 5Y
-1 634.9
Industry
4.6
Forward
0.8
vs History
0
vs Industry
21
Median 3Y
-86.1
Median 5Y
-1 630.2
Industry
4.5
Forward
0.8
vs History
0
vs Industry
25
Median 3Y
-79.1
Median 5Y
-1 705
Industry
4.9
vs History
0
vs Industry
21
Median 3Y
-79.1
Median 5Y
-1 705
Industry
3.7
vs History
vs Industry
3
Median 3Y
-533.2
Median 5Y
-31 815.6
Industry
4.9

Multiples Across Competitors

BGBIO Competitors Multiples
Bergenbio ASA Competitors

Market Cap P/S P/E EV/EBITDA EV/EBIT
NO
Bergenbio ASA
OSE:BGBIO
53.3m NOK 62.9 -0.4 0.6 0.6
FR
Pharnext SCA
OTC:PNEXF
6T USD 34 536 021.3 -164 144.6 -199 323.9 -197 049.4
US
Abbvie Inc
NYSE:ABBV
329.6B USD 5.8 79.4 15.1 22.4
US
Amgen Inc
NASDAQ:AMGN
156.3B USD 4.6 26.3 14.2 23.4
US
Gilead Sciences Inc
NASDAQ:GILD
134.7B USD 4.7 22.6 9.8 13.6
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
114.6B USD 10.3 -116.5 24.6 25.8
US
Epizyme Inc
F:EPE
94.1B EUR 2 039.9 -520.5 -566.8 -551.7
AU
CSL Ltd
ASX:CSL
117.2B AUD 5 27.6 17 21.3
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
55.7B USD 4 12.4 11 12.3
US
Seagen Inc
F:SGT
39.3B EUR 19.6 -60.3 -64.9 -58.6
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
40.8B USD 17.4 -151.2 -677.5 -339.5
P/S Multiple
Revenue Growth P/S to Growth
NO
B
Bergenbio ASA
OSE:BGBIO
Average P/S: 3 139 835.9
62.9
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
34 536 021.3
N/A N/A
US
Abbvie Inc
NYSE:ABBV
5.8
8%
0.7
US
Amgen Inc
NASDAQ:AMGN
4.6
4%
1.1
US
Gilead Sciences Inc
NASDAQ:GILD
4.7
3%
1.6
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
10.3
10%
1
US
E
Epizyme Inc
F:EPE
2 039.9
N/A N/A
AU
CSL Ltd
ASX:CSL
5
7%
0.7
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
4
4%
1
US
S
Seagen Inc
F:SGT
19.6
30%
0.7
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
17.4
29%
0.6
P/E Multiple
Earnings Growth PEG
NO
B
Bergenbio ASA
OSE:BGBIO
Average P/E: 33.7
Negative Multiple: -0.4
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -164 144.6 N/A N/A
US
Abbvie Inc
NYSE:ABBV
79.4
88%
0.9
US
Amgen Inc
NASDAQ:AMGN
26.3
45%
0.6
US
Gilead Sciences Inc
NASDAQ:GILD
22.6
188%
0.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -116.5 N/A N/A
US
E
Epizyme Inc
F:EPE
Negative Multiple: -520.5 N/A N/A
AU
CSL Ltd
ASX:CSL
27.6
16%
1.7
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
12.4
7%
1.8
US
S
Seagen Inc
F:SGT
Negative Multiple: -60.3 N/A N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -151.2 N/A N/A
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
NO
B
Bergenbio ASA
OSE:BGBIO
Average EV/EBITDA: 13.2
0.6
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -199 323.9 N/A N/A
US
Abbvie Inc
NYSE:ABBV
15.1
13%
1.2
US
Amgen Inc
NASDAQ:AMGN
14.2
17%
0.8
US
Gilead Sciences Inc
NASDAQ:GILD
9.8
6%
1.6
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
24.6
17%
1.4
US
E
Epizyme Inc
F:EPE
Negative Multiple: -566.8 N/A N/A
AU
CSL Ltd
ASX:CSL
17
11%
1.5
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
11
11%
1
US
S
Seagen Inc
F:SGT
Negative Multiple: -64.9 N/A N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -677.5 N/A N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
NO
B
Bergenbio ASA
OSE:BGBIO
Average EV/EBIT: 17
0.6
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -197 049.4 N/A N/A
US
Abbvie Inc
NYSE:ABBV
22.4
29%
0.8
US
Amgen Inc
NASDAQ:AMGN
23.4
32%
0.7
US
Gilead Sciences Inc
NASDAQ:GILD
13.6
11%
1.2
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
25.8
17%
1.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -551.7 N/A N/A
AU
CSL Ltd
ASX:CSL
21.3
14%
1.5
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
12.3
11%
1.1
US
S
Seagen Inc
F:SGT
Negative Multiple: -58.6 N/A N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -339.5 N/A N/A